Medicine:Hemoglobin Lepore syndrome

From HandWiki
Hemoglobin Lepore syndrome
Other namesHb Lepore syndrome
Hemoglobin.jpg
A crossover between the delta and beta globin gene loci results in the mutation which causes the Hb Lepore trait.

Hemoglobin Lepore syndrome is typically an asymptomatic hemoglobinopathy, which is caused by an autosomal recessive genetic mutation. The Hb Lepore variant, consisting of two normal alpha globin chains (HBA) and two delta-beta globin fusion chains which occurs due to a "crossover" between the delta (HBD) and beta globin (HBB) gene loci during meiosis and was first identified in the Lepore family, an Italian-American family, in 1958.[1] There are three varieties of Hb Lepore, Washington (Hb Lepore Washington, AKA Hb Lepore Boston or Hb Lepore Washington-Boston), Baltimore (Hb Lepore Baltimore) and Hollandia (Hb Hollandia). All three varieties show similar electrophoretic and chromatographic properties and hematological findings bear close resemblance to those of the beta-thalassemia trait; a blood disorder that reduces the production of the iron-containing protein hemoglobin which carries oxygen to cells and which may cause anemia.

The homozygous state for Hb Lepore is rare. Patients of Balkan descent tend to have the most severe presentation of symptoms including severe anemia during the first five years of life. They also presented with significant splenomegaly, hepatomegaly, and skeletal abnormalities identical to those of homozygous beta-thalassemia. The amount of Hb Lepore in the patients blood ranged from 8 to 30%, the remainder being fetal hemoglobin (Hb F) which is present in minute quantities (typically<1 percent) in the red blood cells of adults. Known as F- cells they are present in a small proportion of overall RBCs.[2]

Homozygous Hb Lepore is similar to beta-thalassemia major; however, the clinical course is variable. Patients with this condition typically present with severe anemia during the first two years of life. The heterozygote form is mildly anemic (Hb 11–13 g/dl) but presents with a significant hypochromia (deficiency of hemoglobin in the red blood cells) and microcytosis.[3][4]

Presentation

Complications

A potential complication that may occur in children that suffer acute anemia with a hemoglobin count below 5.5 g/dl is silent stroke[5][unreliable medical source?] A silent stroke is a type of stroke that does not have any outward symptoms (asymptomatic), and the patient is typically unaware they have suffered a stroke. Despite not causing identifiable symptoms a silent stroke still causes damage to the brain, and places the patient at increased risk for both transient ischemic attack and major stroke in the future.[6]

Cause

Sickle cell-Hb Lepore Boston syndrome is a type of sickle cell disease (HbS) that differs from homozygous sickle cell disease where both parents carry sickle hemoglobin. In this variant one parent has the sickle cell hemoglobin the second parent has Hb Lepore Boston, the only one of the three variants described in association with HbS.[7]

Diagnosis

The diagnosis of Hb Lepore syndrome may be performed antenatally or postnatally via the use of a variety of tests

Treatment

Homozygous Hb Lepore

Those homozygous (Hb LeporeLepore; a very rare situation) or compound heterozygous (Hb Lepore-Β-thalassaemia) might suffer from a severe anaemia. They should be managed in a comprehensive multi-disciplinary program of care.[10] Management includes a regular course of blood transfusions, although the clinical severity in compound (double) heterozygotes can range from minor to major, depending on the combination of genes that have caused the condition.[11]

Heterozygous Hb Lepore

Individuals heterozygous for the Hb Lepore require no particular treatment. There is no anemia or, if there is, it is very mild.[12]

Epidemiology

The Hb Lepore trait has a worldwide distribution and may affect individuals of various ethnicities however the three main varieties which been defined tend to be more prevalent among specific ethnic groups, typically Caucasians of the Southern regions Central and Eastern Europe. The three main varieties are named for the geographical areas they were first identified in with various subtypes, the three main varieties are:[citation needed]

  • Washington (Hb Lepore Washington, also known as Hb Lepore Boston or Hb Lepore Washington-Boston); most common in Italians from Southern Italy[citation needed]
  • Baltimore (Hb Lepore Baltimore); first described in a family with African ancestry; most common in people from the Balkan countries, Albanians Croats, Serbs, Slovenes and Romanians. It has also been described in Turks and in regions of Spain and Portugal. A rare case of the Baltimore variety was discovered in an African American woman in the Bronx, New York and dubbed Hn Lepore-Bronx[13] and another variety was discovered in the city of Saskatoon, Saskatchewan, Canada and dubbed Hb E-Lepore Saskatoon[14]
  • Hollandia (Hb Lepore Hollandia); identified in Papua New Guinea and Bangladesh.[citation needed]

References

  1. ↑ "A new hereditary hemoglobinopathy (the Lepore trait) and its interaction with thalassemia trait". Blood 13 (9): 835–44. September 1958. doi:10.1182/blood.v13.9.835.835. PMID 13572441. 
  2. ↑ "Fetal hemoglobin levels in adults". Blood Rev 8 (4): 213–24. December 1994. doi:10.1016/0268-960x(94)90109-0. PMID 7534152. 
  3. ↑ "[A new case of hemoglobin Lepore-beta-thalassemia disease]" (in Italian). Minerva Med. 73 (5): 191–7. February 1982. PMID 7063135. 
  4. ↑ "An individual with Hb-Lepore-Baltimore- delta beta-thalassaemia in a Yugoslavian family". Scand J Haematol 16 (2): 81–9. February 1976. doi:10.1111/j.1600-0609.1976.tb01122.x. PMID 1257702. 
  5. ↑ "Acute anemia linked to silent strokes in children American Stroke Association Meeting Report: Abstract 185". American Heart Association. 11 February 2011. Archived from the original on 26 July 2011. https://web.archive.org/web/20110726144148/http://www.newsroom.heart.org/index.php?s=43&item=1260. 
  6. ↑ "Silent cerebral infarction is associated with incident stroke and TIA independent of carotid intima-media thickness". Intern Med 49 (9): 817–22. 2010. doi:10.2169/internalmedicine.49.3211. PMID 20453400. 
  7. ↑ "Sickle cell-Hb Lepore Boston syndrome. Uncommon differential diagnosis to homozygous sickle cell disease". Am J Dis Child 136 (1): 19–22. January 1982. doi:10.1001/archpedi.1982.03970370021004. PMID 7055103. 
  8. ↑ Gupta LCPK; Kumar CH; Kumar CCS; Jaiprakash BM (2009). "Cation exchange high performance liquid chromatography for diagnosis of haemoglobinopathies". Med J Armed Forces India 65 (1): 33–37. doi:10.1016/s0377-1237(09)80051-8. PMID 27408187. PMC 4921438. Archived from the original on 11 August 2016. https://web.archive.org/web/20160811234845/http://medind.nic.in/maa/t09/i1/maat09i1p33.pdf. 
  9. ↑ Almon McKusick; Stylianos E. Antonarakis (1998). Mendelian Inheritance in Man: A Catalog of Human Genes and Genetic Disorders (12th ed.). Johns Hopkins University Press. p. 849. ISBN 0-8018-5742-2. https://archive.org/details/mendelianinherit00mcku/page/849. 
  10. ↑ "Haemoglobin Lepore – Anaemias – Enerca". http://www.enerca.org/anaemias/48/haemoglobin-lepore. 
  11. ↑ http://nefeli.lib.teicrete.gr/browse/seyp/nos/2009/AmyrialakiMaria,LerakiDimitra,SifalakiIouliaNektaria/attached-document-1285754310-610362-24189/Amyrialaki2009.pdf [bare URL PDF]
  12. ↑ "Haemoglobin Lepore – Anaemias – Enerca". http://www.enerca.org/anaemias/48/haemoglobin-lepore. 
  13. ↑ "Rare occurrence of Hb Lepore-Baltimore in African Americans: molecular characteristics and variations of Hb Lepores". Ann Hematol 88 (6): 545–8. June 2009. doi:10.1007/s00277-008-0631-4. PMID 18989669. 
  14. ↑ "The first case of Hb E-Saskatoon associated with Hb Lepore-Baltimore found in Spain". Hemoglobin 29 (3): 215–9. 2005. doi:10.1081/hem-200066321. PMID 16114185. 



Retrieved from "https://handwiki.org/wiki/index.php?title=Medicine:Hemoglobin_Lepore_syndrome&oldid=3268716"